These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10711552)

  • 1. Direct transport of progesterone from vagina to uterus.
    Cicinelli E; de Ziegler D; Bulletti C; Matteo MG; Schonauer LM; Galantino P
    Obstet Gynecol; 2000 Mar; 95(3):403-6. PubMed ID: 10711552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of uterine specificity of vaginal progesterone.
    Cicinelli E; Schonauer LM; Galantino P; Matteo MG; Cassetta R; Pinto V
    Hum Reprod; 2000 Jun; 15 Suppl 1():159-65. PubMed ID: 10928427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug delivery in gynaecology: the first uterine pass effect.
    Bulletti C; de Ziegler D; Flamigni C; Giacomucci E; Polli V; Bolelli G; Franceschetti F
    Hum Reprod; 1997 May; 12(5):1073-9. PubMed ID: 9194669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.
    Miles RA; Paulson RJ; Lobo RA; Press MF; Dahmoush L; Sauer MV
    Fertil Steril; 1994 Sep; 62(3):485-90. PubMed ID: 8062942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High local endometrial effect of vaginal progesterone gel.
    Ficicioglu C; Gurbuz B; Tasdemir S; Yalti S; Canova H
    Gynecol Endocrinol; 2004 May; 18(5):240-3. PubMed ID: 15346659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.
    Cicinelli E; de Ziegler D
    Hum Reprod Update; 1999; 5(4):365-72. PubMed ID: 10465526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert.
    Paulson RJ; Collins MG; Yankov VI
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4241-9. PubMed ID: 24606090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with a novel vaginal progesterone preparation in a donor oocyte program.
    Gibbons WE; Toner JP; Hamacher P; Kolm P
    Fertil Steril; 1998 Jan; 69(1):96-101. PubMed ID: 9457941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular versus Vaginal Progesterone Administration in Medicated Frozen Embryo Transfer Cycles: A Randomized Clinical Trial Assessing Sub-Endometrial Contractions.
    Hershko Klement A; Samara N; Weintraub A; Mitri F; Bentov Y; Chang P; Nayot D; Casper RF
    Gynecol Obstet Invest; 2018; 83(1):40-44. PubMed ID: 28501869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Borraccino V; Petruzzi D; Mazzotta N; Cerundolo ML; Schönauer LM
    Fertil Steril; 1996 Apr; 65(4):860-2. PubMed ID: 8654651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first uterine pass effect.
    De Ziegler D; Bulletti C; De Monstier B; Jääskeläinen AS
    Ann N Y Acad Sci; 1997 Sep; 828():291-9. PubMed ID: 9329850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
    Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
    Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycle dependent variations in transfer of 133xenon from vagina to uterus in rats.
    Zhao J; Einer-Jensen N
    Maturitas; 1998 Jan; 28(3):267-70. PubMed ID: 9571603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Cignarelli M; Sabatelli S; Romano F; Schonauer LM; Padovano R; Einer-Jensen N
    Fertil Steril; 1998 Mar; 69(3):471-3. PubMed ID: 9531879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone administration in patients with absent ovaries.
    Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine contractility: vaginal administration of the beta-adrenergic agonist, terbutaline. Evidence of direct vagina-to-uterus transport.
    Bulletti C; de Ziegler D; de Moustier B; Polli V; Bolelli G; Franceschetti F; Flamigni C
    Ann N Y Acad Sci; 2001 Sep; 943():163-71. PubMed ID: 11594537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: Evaluation of vaginal discharge following treatment with a progesterone insert.
    Fischer-Tenhagen C; von Krueger X; Heuwieser W
    J Dairy Sci; 2012 Aug; 95(8):4447-51. PubMed ID: 22818458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF; Diamond MP; Abuzeid M
    Fertil Steril; 2010 Feb; 93(2):554-69. PubMed ID: 19362305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment with two intravaginal inserts on the uterine and vaginal microflora of early postpartum beef cows.
    Padula AM; Macmillan KL
    Aust Vet J; 2006 Jun; 84(6):204-8. PubMed ID: 16821488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.